All stock lists
Editas Medicine, Inc. (NASDAQ:EDIT)
US · Delayed Price · Currency is USD
2.40-0.09 (-3.61%)
Insider Score
––Not scored
EDIT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
EDIT analyst forecast
EDIT analyst consensus
No analyst ratings in the last 3 months.
EDIT 12-month price target
$5.00+109.7% upsideaverage of 1 firm
$5.00High
$5.00Low
Best analysts covering EDIT
No firm covering EDIT has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
EDIT analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| Guggenheim | — | $5.00 | +71.2% | — | 2026-09-23 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.